Antonio Antón

5.1k citations
73 papers · 3.8k · 1 hit paper · h-index 26

Impact in

    • Breast Cancer Treatment Studies
  • Oncology top 2%
    • Colorectal Cancer Treatments and Studies
    • Lung Cancer Research Studies

Papers in

    • Breast Cancer Treatment Studies 18
    • Colorectal Cancer Treatments and Studies 11
    • Cancer Treatment and Pharmacology 6
    • HER2/EGFR in Cancer Research 3

Antonio Antón

69 papers receiving 3.7k citations

Antonio Antón's Hit Papers

Lurbinectedin as second-line treatment for patients with small-cell lung cancer: a single-arm, open-label, phase 2 basket trial 2020 · 367 citations
3670+2+4Years since publication100200300

Peers

Antonio Antón
Comparison fields: 5 of 92
  • Cancer Research 825
  • Oncology 1.3k
  • Otorhinolaryngology 314
  • Pulmonary and Respiratory Medicine 1k
  • Molecular Biology 372
Replace Keisuke Shirai with:
Keisuke Shirai United States
Pavlos Papakostas Greece
Cong Xue China
Audrey Mailliez France
Janakiraman Subramanian United States
Rafael Santana-Dávila United States
Penelope A. Bradbury Canada
Gábor Rubovszky Hungary
Jean–Luc Van Laethem Belgium
Benjamin Philip Levy United States
Antonio Antón relative to Keisuke Shirai United States Keisuke Shirai's profile →
Citations per field
00.5×1.5×2.1×
Keisuke Shirai · 1×
Citations per year

Countries citing papers authored by Antonio Antón

Since Specialization
Citations

This map shows the geographic impact of Antonio Antón's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Antonio Antón with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Antonio Antón more than expected).

Fields of papers citing papers by Antonio Antón

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Antonio Antón. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Antonio Antón. The network helps show where Antonio Antón may publish in the future.

Co-authors

The 25 scholars most cited alongside Antonio Antón, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Antonio Antón Line = papers co-authored together Antonio Antón links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 73 papers — load more, or switch the sort, to bring in the rest.

#Work
1 1999404
2 2016382
3
Lurbinectedin as second-line treatment for patients with small-cell lung cancer: a single-arm, open-label, phase 2 basket trial
Hit paper breakdown →
2020367
4 2005353
5 2012264
6 2012168
7 2000162
8 2018117
9 2019114
10 2015105
11 200988
12 201987
13 200584
14 202170
15 201866
16
Weekly docetaxel as neoadjuvant chemotherapy for stage II and III breast cancer: efficacy and correlation with biological markers in a phase II, multicenter study.
200363
17 200660
18 200153
19 201252
20 200645

About Antonio Antón

Antonio Antón is a scholar working on Cancer Research, Oncology, Pulmonary and Respiratory Medicine, Molecular Biology and Transplantation, having authored 73 papers that have together received 3.8k indexed citations. Recurring topics across this work include Breast Cancer Treatment Studies (18 papers), Colorectal Cancer Treatments and Studies (11 papers), Advanced Breast Cancer Therapies (8 papers), Cancer Treatment and Pharmacology (6 papers), Respiratory Support and Mechanisms (6 papers), Lung Cancer Diagnosis and Treatment (5 papers), Gastric Cancer Management and Outcomes (3 papers) and HER2/EGFR in Cancer Research (3 papers). The work is most often cited by research in Cancer Research (825 citations), Oncology (1.3k citations), Otorhinolaryngology (314 citations), Pulmonary and Respiratory Medicine (1k citations) and Molecular Biology (372 citations). Antonio Antón has collaborated with scholars based in Spain, United Kingdom and Italy. Frequent co-authors include Maria-Rosa Güell-Rous, Alfredo Carrato, Angel Artal, Joaquin Sanchis, Rafael Rosell, Bartomeu Massutí, I. Barneto, María Lomas, Roberto Pazo-Cid and Vicente Alberola. Their work appears in journals such as Journal of Clinical Oncology, Clinical & Translational Oncology, Breast Cancer Research and Treatment, Clinical Cancer Research and Anti-Cancer Drugs.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact